U.S. Anti-Venom Market Size, Share & Trends Analysis Report 2025-2030, Featuring Profiles of Boehringer Ingelheim, CSL, Merck & Co., and Pfizer
The U.S. anti-venom market is buoyed by increased human encounters with venomous species due to urbanization and climate change. Advances in biotechnology enhance treatment efficacy and accessibility, while robust healthcare infrastructure and outdoor activities further drive demand.
U.S. Anti-Venom Market
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) — The “U.S. Anti-Venom Market Size, Share & Trends Analysis Report By Species (Snake, Scorpion, Spider), By Type (Polyvalent, Monovalent), By Mode of Action (Cytotoxic, Neurotoxic), By End Use, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The U.S. anti-venom market size was estimated at…
